Aravind Asokan's Gene Therapy Teamwork with Duke Highlighted

Aravind Asokan's Gene Therapy Teamwork with Duke Highlighted click to enlarge Dr. Aravind Asokan

The collaboration between Aravind Asokan, researcher at the Gene Therapy Center, and Charles Gersbach, a Duke biomedical engineer, to develop gene therapy for Duchenne Muscular Dystrophy - a rapidly worsening form of muscular dystrophy - is spotlighted on UNC's website March 6.

Dr. Asokan's expertise is in gene delivery.  Dr. Gersbach's background is in genome editing.  Together they hope to modify DNA sequences to correct disease-causing mutations.

Read the full article on UNC-Duke research collaborations